ロード中...
Large variety in a panel of human colon cancer organoids in response to EZH2 inhibition
EZH2 inhibitors have gained great interest for their use as anti-cancer therapeutics. However, most research has focused on EZH2 mutant cancers and recently adverse effects of EZH2 inactivation have come to light. To determine whether colorectal cancer cells respond to EZH2 inhibition and to explore...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5342517/ https://ncbi.nlm.nih.gov/pubmed/27634879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|